Danish discovery may change cancer treatment
2015-04-29
(Press-News.org) Danish researchers from the University of Copenhagen and Herlev Hospital have made a discovery that may change the principles for treating certain types of cancer.
The discovery relates to the so-called telomeres that constitute the ends of human chromosomes. Short telomeres are related to unhealthy lifestyles, old age and the male gender - all of which are risk factors in terms of high mortality. Up until now, the assumption has been that short telomeres are related to ill health. The challenge for researchers worldwide has therefore been to find out whether or not the short telomeres were indeed a signifier or an indirect cause of increased mortality.
By studying more than 64,000 Danes from the Oesterbro Study and the Herlev/&Oesterbro Study - the largest telomere-study ever conducted - the researchers have reached the conclusion that the genetically determined length of telomeres has no influence on mortality in general. However, humans with genetically long telomeres have an increased risk of dying from cancer - which is the exact opposite of what the researchers expected to find. And this new knowledge may thus influence future cancer treatments.
"People have long telomeres because their cells are very apt at maintaining and repairing them. The disadvantage is that cancer cells are also very apt at maintaining and repairing their telomeres, which then prohibits the growth-inhibition that short telomeres would normally induce. If you are able to specifically target this repair process, in principle, you are then better able to stop cancer," says Stig Bojesen, Professor at the Faculty of Health and Medical Sciences at the University of Copenhagen and Chief Physician at Herlev Hospital, who has conducted the study in collaboration with Registrar Line Rode and Professor Boerge Nordestgaard.
The method is called telomerase-inhibition and has been studied as a possible cancer treatment since the mid-00s.
"So far, the method has not managed to fulfil the great expectations initially entertained. However, our discovery highlights that the principle of telomerase-inhibition should be afforded an important place in cancer treatment. The next challenge will be trying to locate more precisely, which cancer patients may benefit the most from such treatment," Stig Bojesen concludes.
INFORMATION:
ELSE PRESS RELEASES FROM THIS DATE:
2015-04-29
Putnam Valley, NY. (April 28, 2015) - Mesenchymal stem cells (MSCs) have been transplanted to successfully treat a variety of diseases and conditions. The benefit of using MSCs is their ability to self-renew and differentiate into a variety of specialized cell types, such as osteoblasts (cells contributing to bone formation), chondrocytes (cartilage cells), adipocytes (fat cells), myocardiocytes (the muscle cells that make up the cardiac muscle), and neurons (nervous system cells).
MSCs have shown the ability to modulate the immune response and therefore reduce local ...
2015-04-29
A new study by researchers at the University of California, San Diego School of Medicine has identified demographic, socioeconomic and cultural factors that contribute to a major gender disparity among U.S. men and women undergoing weight loss surgeries. Men undergo the surgeries in far lower numbers than women.
The study is published in the March issue of the Journal of Laparoendoscopic & Advanced Surgical Techniques.
Eighty percent of patients who undergo bariatric surgery, which involve procedures that either limit the amount of food that can be consumed or reduce ...
2015-04-29
DURHAM, N.C. -- The adage "out of sight, out of mind" applies to electricity use, according to new research from Duke University's Sanford School of Public Policy.
A study of 16 years of billing records from one South Carolina utility found that residential customers using automatic bill payments consumed 4 to 6 percent more power than those who did not. Commercial electricity customers used 8 percent more. And low-income residents who enrolled in budget billing to spread the cost of seasonal peak demand across the year used 7 percent more electricity.
"It's a perverse ...
2015-04-29
What do you do when a patient needs a blood transfusion but you don't have their blood type in the blood bank? It's a problem that scientists have been trying to solve for years but haven't been able to find an economic solution - until now.
University of British Columbia chemists and scientists in the Centre for Blood Research have created an enzyme that could potentially solve this problem. The enzyme works by snipping off the sugars, also known as antigens, found in Type A and Type B blood, making it more like Type O. Type O blood is known as the universal donor and ...
2015-04-29
DETROIT - Nearly half of foodborne illnesses in the U.S. from 1998 through 2008 have been attributed to contaminated fresh produce. Prevention and control of bacterial contamination on fresh produce is critical to ensure food safety. The current strategy remains industrial washing of the product in water containing chlorine. However, due to sanitizer ineffectiveness there is an urgent need to identify alternative antimicrobials, particularly those of natural origin, for the produce industry.
A team of researchers at Wayne State University have been exploring natural, ...
2015-04-29
Black and Hispanic patients will less frequently than white patients start hemodialysis with an arteriovenous fistula (connecting an artery to a vein for vascular access), a procedure for initial blood flow access known to result in superior outcomes compared with either catheters or arteriovenous grafts, according to a report published online by JAMA Surgery.
End-stage kidney disease affected more than 593,000 people in the United States in 2010 and more than 383,000 of them were treated with hemodialysis, a process that replaces the blood filtering usually done by the ...
2015-04-29
A high-dose treatment of sodium nitrite, 6 percent, with citric acid, 9 percent, creams applied twice daily was more effective than placebo for treating the common sexually transmitted disease of anogenital warts, according to an article published online by JAMA Dermatology.
The warts are caused by infection with human papillomavirus (HPV) types 6 and 11 in more than 90 percent of cases. Topical therapies and surgical removal of the warts are associated with local adverse reactions that include itching, burning, pain and erosions. Recurrence with existing therapies is ...
2015-04-29
ITHACA, N.Y. - Imagine a hand-held electronic device - accessible, portable and nearly universal - that could reduce pain and discomfort for patients, and allow doctors the freedom to use less powerful and potentially risky medications to complement anesthesia.
Now reach in your pocket, because chances are you already own one.
According to new research from a team led by Communications and Information Science Professor Jeff Hancock and Cornell doctoral student Jamie Guillory (now at RTI International), the simple act of texting someone on a mobile phone during a minor ...
2015-04-29
The National Emphysema Treatment Trial (NETT) was a multicenter, randomized, controlled clinical trial comparing the efficacy of lung volume reduction surgery (LVRS) plus medical management with rehabilitation to medical management plus rehabilitation in patients with severe emphysema. In 2003, the results of NETT demonstrated that LVRS could improve lung function in patients with emphysema, and that the procedure led to improved survival. Yet, adoption of LVRS has been very slow with concerns expressed regarding safety and long-term efficacy. In this presentation, Dr. ...
2015-04-29
Every day, thousands of people need donated blood. But only blood without A- or B-type antigens, such as type O, can be given to all of those in need, and it's usually in short supply. Now scientists are making strides toward fixing the situation. In ACS' Journal of the American Chemical Society, they report an efficient way to transform A and B blood into a neutral type that can be given to any patient.
Stephen G. Withers and colleagues note that currently, blood transfusions require that the blood type of the donor match that of the recipient. If they aren't the same, ...
LAST 30 PRESS RELEASES:
[Press-News.org] Danish discovery may change cancer treatment
